Indoco Remedies posted revenues of Rs. 247.2 crores during the First quarter of FY2019-20, as against Rs. 212.5 crores, for the same quarter last year. For the quarter, the Company posted a profit of Rs. 2.2 crores, as against loss of Rs. 12.0 crores, same quarter last year.
Commenting on the first quarter results, Aditi Panandikar, Managing Director, Indoco Remedies Ltd., said, "Tbe Company's India Business is witnessing a progressive trend, as reflected in the Secondary Sales data as per A WACS and in Prescription (Rx) generation as per SMSRC. With the regulatory challenges easing out, the international business is also poised for a higher growth".
Shares of INDOCO REMEDIES LTD. was last trading in BSE at Rs.152.6 as compared to the previous close of Rs. 152.75. The total number of shares traded during the day was 7924 in over 588 trades.
The stock hit an intraday high of Rs. 163.65 and intraday low of 151.15. The net turnover during the day was Rs. 1239992.